James Armitage
Fortune : 52 231 $ au 31/05/2026
Fortune : 52 231 $ au 31/05/2026
James O.
Armitage is currently Director at Tesaro, Inc. since 2013, Independent Director at Cardiff Oncology, Inc. since 2020, and Professor-Internal Medicine at the University of Nebraska Medical Center since 2003.
Former positions include Director at MGI PHARMA, Inc. from 2006 to 2008, President & Director at the American Society of Clinical Oncology, Inc., and President at the American Society for Blood & Marrow Transplantation.
Education includes undergraduate studies at the University of Nebraska and a doctorate from the University of Nebraska Medical Center.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 27 490 ( 0,04% ) | 52 231 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TESARO INC | Directeur/Membre du Conseil | 09/05/2013 |
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/04/2020 |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1982 |
| Sociétés | Poste | Fin |
|---|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Directeur/Membre du Conseil | 29/01/2008 |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation, now known as the American Society for Transplantation and Cellular Therapy (ASTCT), is an international professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization provides resources such as practice guidelines, coding and billing tools, educational courses, webinars, meetings, specialized training events, publications, podcasts, newsletters, and a fellowship program survey. ASTCT also fosters collaboration, networking, and professional development, and actively engages in advocacy to influence policy, increase research funding, and support legislation to improve patient access to care. Founded in 1993 and renamed in 2019, ASTCT is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, clinical practice, and advocacy. | President | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
University of Nebraska
University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of Nebraska Medical Center
University of Nebraska Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation, now known as the American Society for Transplantation and Cellular Therapy (ASTCT), is an international professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization provides resources such as practice guidelines, coding and billing tools, educational courses, webinars, meetings, specialized training events, publications, podcasts, newsletters, and a fellowship program survey. ASTCT also fosters collaboration, networking, and professional development, and actively engages in advocacy to influence policy, increase research funding, and support legislation to improve patient access to care. Founded in 1993 and renamed in 2019, ASTCT is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, clinical practice, and advocacy. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national